11 John Paulson Teva- Pharmaceutical Industries Ltd. Trades
John Paulson started to build up the position in Teva- Pharmaceutical Industries Ltd. in Q2 2015 and continued to invest until Q1 2016. Since then they sold 20.6 Million shares. The investor completely sold their stake between Q2 2016 and Q4 2017.
Avg closing price
Price range
Sold -2.45 Million shares
Q4 2017
Avg closing price
$15.04
Price range
$11.23
-
$19.10
Sold 63.7% shares (-4.29 Million shares)
Q3 2017
Avg closing price
$22.50
Price range
$15.41
-
$33.31
Sold 38.7% shares (-4.25 Million shares)
Q2 2017
Avg closing price
$30.95
Price range
$27.82
-
$33.22
Sold 30.9% shares (-4.93 Million shares)
Q1 2017
Avg closing price
$34.13
Price range
$32.09
-
$37.96
Sold 0.9% shares (-151 Thousand shares)
Q4 2016
Avg closing price
$39.93
Price range
$35.03
-
$45.68
Sold 4.2% shares (-697 Thousand shares)
Q3 2016
Avg closing price
$52.17
Price range
$46.01
-
$55.45
Sold 18.6% shares (-3.83 Million shares)
Q2 2016
Avg closing price
$53.24
Price range
$48.53
-
$57.25
Increased shares by 0.9% (+193 Thousand shares)
Q1 2016
Avg closing price
$58.67
Price range
$53.50
-
$65.86
Increased shares by 13.4% (+2.41 Million shares)
Q4 2015
Avg closing price
$61.80
Price range
$55.96
-
$66.32
Increased shares by 786.5% (+16 Million shares)
Q3 2015